More Company News

Scancell

Positive data from first stage of SCIB1 Phase II SCOPE trial in advanced melanoma
19 Sep 2023Read More

Scancell

Appointment of Head of Business Development
07 Sep 2023Read More

Scancell

Appointment of CFO
29 Aug 2023Read More

Scancell

Modi-1 trial open for expansion in CPI combination
31 Jul 2023Read More

Scancell

Pipeline strategy and business update
10 Jul 2023Read More

Scancell

ModiFY Phase I/II data at ASCO 2023
02 Jun 2023Read More

Scancell

ModiFY Phase 1/2 poster at AACR 2023
18 Apr 2023Read More

Scancell

Encouraging early efficacy data from ModiFY trial
21 Feb 2023Read More

Scancell

Positive response in COVIDITY trial
13 Feb 2023Read More

Scancell

Dr Jean-Michel Cosséry appointed Chairman
01 Feb 2023Read More

1 2 3 4 … 9
Return to Scancell
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).